Obesity / weight management clinical trials recruiting in Texas

119 recruiting obesity / weight management trials match in Texas. Showing 20.

• A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or TirzepatideRecruiting

  Phase 2 · Eli Lilly and Company · Houston, Texas

• A Study to Evaluate Tradipitant on Treating Nausea and Vomiting Induced by GLP-1R Agonist UseRecruiting

  Phase 3 · Vanda Pharmaceuticals · Los Angeles, California

• A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or OverweightRecruiting

  Phase 2 · Eli Lilly and Company · Austin, Texas

• Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral AdiposityRecruiting

  N/A · University of Texas Southwestern Medical Center · Dallas, Texas

• A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly IncretinRecruiting

  Phase 3 · Eli Lilly and Company · Dallas, Texas

• AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce PainRecruiting

  Phase 3 · Novo Nordisk A/S · Dallas, Texas

• Healthy Living BEYOND Weight StudyRecruiting

  N/A · American Heart Association · Dallas, Texas

• A Study of LY4064912 in Healthy Participants and With Overweight or ObesityRecruiting

  Phase 1 · Eli Lilly and Company · San Antonio, Texas

• Glycemic and Weight Loss Effects of GLP-1R Agonist Therapy in Subjects With Spinal Cord Injury and Type 2 DiabetesRecruiting

  Phase 4 · Marzieh Salehi · San Antonio, Texas

• Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)Recruiting

  Early Phase 1 · University of Texas Southwestern Medical Center · Dallas, Texas

• A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or OverweightRecruiting

  Phase 2 · Eli Lilly and Company · Austin, Texas

• Maridebart Cafraglutide Versus Placebo in Adult Participants With Obstructive Sleep Apnea on Positive Airway Pressure TherapyRecruiting

  Phase 3 · Amgen · Austin, Texas

• Self-monitoring Focus Groups With Vibrant Lives Pasadena ParticipantsRecruiting

  N/A · M.D. Anderson Cancer Center · Houston, Texas

• A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)Recruiting

  Phase 4 · Eli Lilly and Company · Colleyville, Texas

• Reducing Obesity Through Play Among Toddlers: Tiny Steps to Health (TSHS) StudyRecruiting

  N/A · University of Houston · Houston, Texas

• A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or OverweightRecruiting

  Phase 2 · Boehringer Ingelheim · Birmingham, Alabama

• Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)Recruiting

  Phase 3 · Amgen · DeSoto, Texas

• A Study of Pitolisant in Patients With Prader-Willi SyndromeRecruiting

  Phase 3 · Harmony Biosciences Management, Inc. · Houston, Texas

• Safely Optimizing Body Weight With TCMCB07 in Patients With Newly Diagnosed Colorectal Cancer Undergoing ChemotherapyRecruiting

  Phase 2 · Endevica Bio · Kingwood, Texas

• A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DMRecruiting

  Phase 1 / Phase 2 · Alnylam Pharmaceuticals · Mount Royal

Source: ClinicalTrials.gov. Recruitment status changes often — confirm on each study page.